Design Therapeutics Inc. (DSGN)

4.50

-0.36 (-7.41%)

At close: Mar 03, 2025, 3:59 PM

4.52

0.33%

After-hours: Mar 03, 2025, 04:00 PM EST

Design Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-66.86M	-63.31M	-35.53M	-8.28M	-2.05M
Depreciation & Amortization	537K	406K	129K	5K	n/a
Stock-Based Compensation	13.09M	10.93M	4.69M	450K	n/a
Other Working Capital	1.97M	-3.39M	-1.02M	-398K	1.81M
Other Non-Cash Items	-6.05M	-1.33M	19K	38K	95K
Deferred Income Tax	n/a	n/a	-77K	-71K	n/a
Change in Working Capital	728K	1.99M	1.4M	-811K	1.81M
Operating Cash Flow	-58.56M	-51.32M	-29.38M	-8.67M	-139K
Capital Expenditures	-256K	-918K	-1.54M	-76K	n/a
Acquisitions	n/a	39K	52.11K	33.48K	n/a
Purchase of Investments	-224.7M	-313M	-86.26M	-55.59M	n/a
Sales Maturities Of Investments	277.5M	92.89M	34.16M	22.1M	n/a
Other Investing Acitivies	n/a	39K	-52.11K	-33.48K	n/a
Investing Cash Flow	52.54M	-220.99M	-53.64M	-33.56M	n/a
Debt Repayment	n/a	n/a	n/a	44.53M	196K
Common Stock Repurchased	305K	339K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	724K	235K	124.94M	1K	n/a
Financial Cash Flow	724K	235.00	379.21K	44.53M	196K
Net Cash Flow	-5.3M	-272.07M	296.19M	2.3M	57K
Free Cash Flow	-58.82M	-52.23M	-30.91M	-8.74M	-139K